Sightsavers Nigeria
Integrating NTD programme monitoring into routine health systems data: evaluating a DHIS2 platform for real-time mass administration of medicines (MAM) reporting
Primary Research Question: What are the factors shaping the implementation of NTD control programme in Nigeria?
Secondary Research Questions:
1. Does the DHIS2 tool provide a reliable estimate of treatment coverage?
2. What improvements or adaptations are required to the tool or processes around use of the tool?
3. Can the tool be scaled up regardless of funder and location?
4. Does the tool enhance government ownership of the data and the MDA programme in general?
Factors affecting the persistence of active trachoma in Silame and Binji Local Government Areas of Sokoto State, Nigeria
What are the Ct transmission dynamics in Binji and Silame LGAs, of Sokoto State and does this confirm persistence of trachoma (and need for continued MDA) as indicated in the latest impact survey?
1. Are there any particular geographical locations or groups that have higher Ct infection and therefore driving persistence of infection and /or on-going transmission?
2. What are the underlying (epidemiological, programmatic, contextual, and socio-behavioral) factors contributing to persistent active trachoma despite delivery of the recommended SAFE intervention strategies in Binji and Silame districts of Sokoto state?
Evaluation of MDA restart in the context of COVID-19 in Kwara and Kano, Nigeria
1. Can MDA resume and achieve high performance while minimizing risk of COVID-19 transmission through adherence to SOPs?
2. Can local teams easily implement the recommended modifications to MDAs; what is the added cost; and how do the above vary by context?
3. What aspects of local context influence implementation of SOPs?
Evaluation of MDA restart in the context of COVID-19 in Kwara and Kano, Nigeria
1. Can MDA resume and achieve high performance while minimizing risk of COVID-19 transmission through adherence to SOPs?
2. Can local teams easily implement the recommended modifications to MDAs; what is the added cost; and how do the above vary by context?
3. What aspects of local context influence implementation of SOPs?
Integrating NTD programme monitoring into routine health systems data: evaluating a DHIS2 platform for real-time mass administration of medicines (MAM) reporting
Primary Research Question: What are the factors shaping the implementation of NTD control programme in Nigeria?
Secondary Research Questions:
1. Does the DHIS2 tool provide a reliable estimate of treatment coverage?
2. What improvements or adaptations are required to the tool or processes around use of the tool?
3. Can the tool be scaled up regardless of funder and location?
4. Does the tool enhance government ownership of the data and the MDA programme in general?
Evaluation of MDA restart in the context of COVID-19 in Kwara and Kano, Nigeria
1. Can MDA resume and achieve high performance while minimizing risk of COVID-19 transmission through adherence to SOPs?
2. Can local teams easily implement the recommended modifications to MDAs; what is the added cost; and how do the above vary by context?
3. What aspects of local context influence implementation of SOPs?
Interrogating “big data” to develop a user-friendly analysis framework for gender equity in MDA to ensure no one is left behind in Neglected Tropical Disease interventions in Nigeria
To develop and pilot a standardised analytical framework for the spatial and temporal analysis of routinely collected gender disaggregated NTD programme data. This will allow increased understanding and spatial visualisation of the influence of gendered programmatic inputs, external geographic and social factors on the equity of programmatic outputs, particularly access to mass administration of medicines (MAM).